Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Upstaza (Eladocagene exuparvovec) solution for infusion {equilateral_black_triangle}

Active Ingredient:
eladocagene exuparvovec
Company:  
PTC Therapeutics Ltd See contact details
ATC code: 
A16AB26
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Upstaza Patient Alert Card

{healthcare_pro_orange} For Healthcare Professionals

Patient alert card for patient/caregivers treated with Upstaza (eladocagene exuparvovec) gene therapy.

{pdf_link}

Upstaza Pharmacy Manual

{healthcare_pro_orange} For Healthcare Professionals

Version 2 of the Upstaza Pharmacy Manual

{pdf_link}

Upstaza Surgical Guide

{healthcare_pro_orange} For Healthcare Professionals

Version 2 of the Upstaza Surgical Guides

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

PTC Therapeutics Ltd
Company image
Address
Building 2, Ground Floor, Guildford Business Park, Guildford, GU2 8XG, UK
WWW
http://www.ptcbio.co.uk
Telephone
+44 (0)1483 935 709
Medical Information Direct Line
0345 075 4864
Medical Information e-mail
[email protected]